In a preclinical study of ischemic stroke, Nevirapine administration offered neuroprotective effects by reducing hippocampal levels of acetylcholinesterase (AChE) and glutamate following MCAO in rats (Pathakala et al., 2016). This evidence concerns the gene ACHE and ischemic stroke.